US government does not own any remdesivir patents, GAO report finds

The US federal government’s contributions to research on Gilead’s Covid-19 antiviral drug remdesivir did not result in any patent rights because the research did not create new inventions, the Government Accountability Office said in a report on Wednesday afternoon.

The report settles a longstanding dispute over whether the government might...

Click to view original post